Centene (CNC) Stock Forecast & Price Target

Centene reported a Medicaid Health Benefits Ratio (HBR) of 93.4% in 3Q25, reflecting a year-over-year improvement and enhanced rate visibility, which is expected to drive continued premium revenue growth. The company's membership in 3.5+ Star Medicare plans has increased to 60%, indicating a strengthening position in the Medicare market, while Medicare membership reached approximately 1.01 million, exceeding expectations. Additionally, the average rates for the 9/1 and 10/1 cohorts are projected to contribute to an overall composite rate improvement of around 5.5%, bolstering future revenue prospects.

Centene's stock outlook is negatively impacted by several fundamental concerns, including a significant reduction in the percentage of its portfolio allocated to low-cost Silver positions, which dropped from 55% in 2025 to an expected 42% in 2026. The company is facing ongoing challenges, such as a deterioration of Marketplace risk scores and continued pressure on Medicaid margins, which together create uncertainty for future earnings stability. Additionally, risks related to government pay exposure, adverse regulatory changes, and challenges in the Medicare Part D business further complicate Centene's financial prospects, suggesting a cautious approach to its investment potential.